There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive.

Details

Language :

English

ISSN :

0732183X

Volume :

36

Issue :

30

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

132491461

Full Text :

https://doi.org/10.1200/JCO.2018.79.3166